EMFO LLC’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$643K Buy
28,554
+8,129
+40% +$243K 0.58% 42
2024
Q1
$1.05M Buy
20,425
+300
+1% +$16.7K 0.96% 28
2023
Q4
$1.42M Buy
20,125
+42
+0.2% +$2.9K 1.31% 24
2023
Q3
$1.48M Buy
20,083
+1,475
+8% +$153K 1.39% 23
2023
Q2
$2.78M Buy
18,608
+5,467
+42% +$756K 2.52% 8
2023
Q1
$696K Buy
13,141
+7,559
+135% +$454K 0.66% 42
2022
Q4
$513K Sell
5,582
-1,155
-17% -$250K 0.51% 47
2022
Q3
$1.56M Buy
6,737
+504
+8% +$126K 1.48% 17
2022
Q2
$1.16M Hold
6,233
1.18% 25
2022
Q1
$2.44M Hold
6,233
2.21% 7
2021
Q4
$2.19M Sell
6,233
-1,060
-15% -$506K 1.94% 13
2021
Q3
$3.6M Buy
7,293
+192
+3% +$94.6K 3.17% 2
2021
Q2
$3.51M Buy
+7,101
New +$3.48M 3.07% 3

Other funds holding PIII

EMFO LLC's PIII Position: Q2 2024 in Review

EMFO LLC increased its P3 Health Partners (PIII) stake by 40% in Q2 2024, buying an estimated $243K and bringing the position to 28,554 shares worth $643K. The position accounts for 0.58% of the portfolio, ranked #42.

EMFO LLC first reported a position in PIII in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.6M in Q3 2021. 60 funds tracked by Wall St. Rank hold PIII as of Q2 2024.

  • EMFO LLC held 28,554 shares of P3 Health Partners worth $643K as of Q2 2024.
  • EMFO LLC bought 8,129 P3 Health Partners shares in Q2 2024, an estimated $243K.
  • P3 Health Partners made up 0.58% of EMFO LLC's portfolio in Q2 2024, its #42 holding.
  • EMFO LLC first reported a position in P3 Health Partners in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's P3 Health Partners position peaked at $3.6M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.